Improvement of symptoms of psoriasis patients by boswellia gel

Comparing the efficacy of Boswellia nanoemulsion gel in improving symptoms in psoriasis patients compared to the control group

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240622062209N1

Enrollment

Registered

2024-09-04

Start date

2024-08-22

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis. Psoriasis

Interventions

Intervention 1: Intervention group: Receive boswellia nanoemulsion gel , In a period of one month, it is given to the patient to apply it to the lesion three times a day. After a month, the doctor wil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients are included in the study with indications for topical treatment as determined by a dermatologist Patients with lesions in both hands

Exclusion criteria

Exclusion criteria: Pregnancy Breastfeeding Being allergic to the product

Design outcomes

Primary

Measure	Time frame
Psoriasis Area and Severity Index (PASI). Timepoint: Before starting the study, 2nd, 4th, 6th and 8th week after starting the study. Method of measurement: Psoriasis level and intensity measurement index is a combination of evaluation of the severity of lesions and extent of affected area, which is calculated as a score between 0 (no disease) and 72 (maximum disease). It is done by the doctor in the form of observation and measurement.	—

Measure

Time frame

Psoriasis Area and Severity Index (PASI). Timepoint: Before starting the study, 2nd, 4th, 6th and 8th week after starting the study. Method of measurement: Psoriasis level and intensity measurement index is a combination of evaluation of the severity of lesions and extent of affected area, which is calculated as a score between 0 (no disease) and 72 (maximum disease). It is done by the doctor in the form of observation and measurement.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtena Mansouri

Birjand University of Medical Sciences

mansouri_atena@yahoo.com+98 56 3238 1259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026